Research location
St Leonards
New South Wales, Australia
Advertisement
Research activity in St Leonards
New South Wales, AustraliaCureCurrent currently publishes aggregate city-level research activity for this location: 205 trials and 211 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in St Leonards
205 linked trials · page 2 of 5Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) MutationsNCT05364073 · 2022-06-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisNCT05269004 · 2022-05-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)NCT05173987 · 2022-02-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)NCT04956640 · 2021-07-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal RadiationNCT04909125 · 2021-06-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung CancerNCT04746924 · 2021-05-24 · 1 site observation
TERMINATED
Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast CancerNCT04857619 · 2021-05-14 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative TherapyNCT04873362 · 2021-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney DiseaseNCT04750577 · 2021-04-27 · 1 site observation
COMPLETED
Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast CancerNCT04739670 · 2021-03-01 · 1 site observation
UNKNOWN
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate CancerNCT04736199 · 2021-02-23 · 1 site observation
COMPLETED
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)NCT04509674 · 2020-12-16 · 1 site observation
COMPLETED
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)NCT04585815 · 2020-11-10 · 2 site observations
TERMINATED
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)NCT04597125 · 2020-11-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing ChemotherapyNCT04471428 · 2020-10-01 · 1 site observation
COMPLETED
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)NCT04411641 · 2020-09-24 · 1 site observation
COMPLETED
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)NCT04458051 · 2020-08-13 · 1 site observation
COMPLETED
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)NCT04222972 · 2020-07-24 · 1 site observation
TERMINATED
Mayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoNCT05826028 · 2020-07-09 · 1 site observation
COMPLETED
In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to ChemotherapyNCT04343885 · 2020-04-21 · 1 site observation
ACTIVE_NOT_RECRUITING
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsNCT04129502 · 2020-01-10 · 1 site observation
ACTIVE_NOT_RECRUITING
Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)NCT04051827 · 2019-12-23 · 1 site observation
COMPLETED
A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast CancerNCT04177108 · 2019-11-25 · 1 site observation
COMPLETED
A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical PracticeNCT04042441 · 2019-07-29 · 1 site observation
COMPLETED
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)NCT03924869 · 2019-06-25 · 1 site observation
TERMINATED
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseNCT03819153 · 2019-06-17 · 1 site observation
COMPLETED
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)NCT03711032 · 2018-12-24 · 2 site observations
ACTIVE_NOT_RECRUITING
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerNCT03701334 · 2018-12-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab AdministrationNCT03689972 · 2018-11-27 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskNCT03730662 · 2018-11-20 · 1 site observation
COMPLETED
Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving IrbesartanNCT03627715 · 2018-11-06 · 1 site observation
COMPLETED
Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)NCT03635567 · 2018-10-25 · 1 site observation
COMPLETED
Optimal Prostate StudyNCT03386045 · 2018-10-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Breast Radiotherapy Audio Visual Enhancement for Sparing the HeartNCT02881203 · 2018-09-15 · 1 site observation
COMPLETED
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung CancerNCT03456076 · 2018-08-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes MellitusNCT03428945 · 2018-08-15 · 1 site observation
TERMINATED
A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid TumoursNCT03468426 · 2018-07-05 · 1 site observation
COMPLETED
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation
COMPLETED
Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 DiabetesNCT03377699 · 2017-11-22 · 1 site observation
COMPLETED
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsNCT03330405 · 2017-10-19 · 1 site observation
TERMINATED
A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)NCT03234712 · 2017-10-10 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)NCT03178552 · 2017-09-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate CancerNCT03041285 · 2017-08-31 · 1 site observation
TERMINATED
A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have SpreadNCT03098550 · 2017-06-15 · 1 site observation
COMPLETED
Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 YearsNCT03179423 · 2017-06-14 · 1 site observation
COMPLETED
Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid TumorsNCT03102320 · 2017-05-26 · 1 site observation
COMPLETED
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)NCT03157128 · 2017-05-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)NCT03085810 · 2017-03-24 · 1 site observation
TERMINATED
A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid TumorsNCT02955251 · 2016-11-18 · 1 site observation
COMPLETED
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple SclerosisNCT02792218 · 2016-09-20 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.